4
Changes in Ownership
Trevi Therapeutics, Inc. Filed Acc 0001209191-23-010190
Options or other derivatives
- Chief Commercial Officer acquired 100,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Simon Farrell · Chief Commercial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-02-16 | Grant or award : show line 1 in the form Stock Option (right to buy) | +100,000 | 100,000 | D |
Loading xslF345X03/doc4.xml…